Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Plos One|May 8, 2026
Machine learning-based model for predicting recanalization in isolated distal deep vein thrombosis and analysis of predictorsYingjie Kuang, Jun Zhang, Zhen An, et al.Genome Biology|April 1, 2026
RNA modification-mediated multidimensional crosstalk: a novel perspective on gene expression regulationYan Wang, Chunxu Yang, Rongjie Lin, et al.Cancer Innovation|December 13, 2023
Characteristics of homologous recombination repair pathway genes mutation in ovarian cancersZongbi Yi, Min Chen, Shaoxing Sun, et al.Journal of Personalized Medicine|May 25, 2024
Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies AheadYan Wang, Hui Qiu, Rongjie Lin, et al.Molecular and Clinical Oncology|April 29, 2014
Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents: A meta-analysisShaoxing Sun, Zonghuan Li, Li Sun, et al.Oncotarget|October 27, 2016
Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growthBo Yang, Shiming Zhang, Zhihao Wang, et al.Animal Bioscience|March 3, 2022
Maternal nutrition altered embryonic MYOD1, MYF5, and MYF6 gene expression in genetically fat and lean lines of chickensFeng Li, Chunxu Yang, Yingjie Xie, et al.International Journal of Oncology|December 22, 2012
Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cellsWen Ouyang, Chunxu Yang, Simin Zhang, et al.Oncology Reports|August 15, 2018
α7‑nAchR agonist GTS‑21 reduces radiation‑induced lung injuryZijie Mei, Xiaoli Tian, Jing Chen, et al.Drug Design, Development and Therapy|November 24, 2021
A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line TherapyHui Yang, Shaoxing Sun, Zijie Mei, et al.Pageof 4